AZ
Ajayrajsinh R. Zala
Teva API india, Zydus Lifesciences Limited, Sardar Vallabhbhai National Institute of Technology Surat
Employment
-
Teva API india Chemical Researcher2025 - Present
-
Zydus Lifesciences Limited Research Scientist2023 - 2025
Education
-
Sardar Vallabhbhai National Institute of Technology Surat PhD Research Scholar2018 - 2023
Projects & Funding
Projects & funding information is unavailable.
Publications (11)
- Exploring the Antimycobacterial Potential of Purine‐Piperazine Hybrids via in Vitro and in Silico Approaches Save
- Remediation of Wastewater through Photo‐Induced Catalytic and Electrochemical Hydrogen Production Save
- Synthesis, characterization, molecular dynamic simulation, and biological assessment of cinnamates linked to imidazole/benzimidazole as a CYP51 inhibitor Save
- Versatile Therapeutic Values of N‐Containing Heterocycles Benzimidazole, Piperazine and Piperidine Hybrids Save
- Design and synthesis of novel 1,2,3-triazole linked hybrids: Molecular docking, MD simulation, and their antidiabetic efficacy as α-Amylase inhibitors Save
- Design and synthesis of pyrrolo[2,3-d]pyrimidine linked hybrids as α-amylase inhibitors: molecular docking, MD simulation, ADMET and antidiabetic screening Save
- Molecular modeling and biological investigation of novel s-triazine linked benzothiazole and coumarin hybrids as antimicrobial and antimycobacterial agents Save
- Design, synthesis, molecular docking and in silico ADMET investigations of novel piperidine-bearing cinnamic acid hybrids as potent antimicrobial agents Save
- Synthesis, molecular docking, ADME study, and antimicrobial potency of piperazine based cinnamic acid bearing coumarin moieties as a DNA gyrase inhibitor Save
- Design, synthesis, molecular docking and antimicrobial and antimycobacterial activities of novel hybrid of coumarin-cinnamic acids Save